Hyperuricemia and gout. Classification, complications and management

N Engl J Med. 1979 Jun 28;300(26):1459-68. doi: 10.1056/NEJM197906283002604.
No abstract available

Publication types

  • Review

MeSH terms

  • Acute Disease
  • Allopurinol / therapeutic use
  • Arthritis / drug therapy
  • Arthritis / metabolism
  • Aspirin / adverse effects
  • Colchicine / therapeutic use
  • Coronary Disease / etiology
  • Diuretics / adverse effects
  • Gout / classification
  • Gout / diagnosis*
  • Gout / drug therapy
  • Humans
  • Hypoxanthine Phosphoribosyltransferase / deficiency
  • Indomethacin / therapeutic use
  • Kidney / physiology
  • Kidney Calculi / etiology
  • Kidney Diseases / etiology
  • Lead Poisoning / complications
  • Lymphoproliferative Disorders / complications
  • Myeloproliferative Disorders / complications
  • Phenylbutazone / therapeutic use
  • Platelet Aggregation
  • Probenecid / therapeutic use
  • Purine-Pyrimidine Metabolism, Inborn Errors / complications
  • Pyrazinamide / adverse effects
  • Ribose-Phosphate Pyrophosphokinase / deficiency
  • Ribose-Phosphate Pyrophosphokinase / metabolism
  • Uric Acid / blood*
  • Uric Acid / metabolism
  • Uric Acid / urine
  • Uricosuric Agents / therapeutic use

Substances

  • Diuretics
  • Uricosuric Agents
  • Uric Acid
  • Pyrazinamide
  • Allopurinol
  • Hypoxanthine Phosphoribosyltransferase
  • Ribose-Phosphate Pyrophosphokinase
  • Phenylbutazone
  • Probenecid
  • Aspirin
  • Colchicine
  • Indomethacin